Aims of Attendees at GSS 2011

Delegates

It is clear that effective brand security strategies must depend upon cohesive alliances and partnerships from across the value chain – from brand owners, technology suppliers and packaging converters to retailers, consumers, regulators and law enforcement agencies. It is the aim of the Global Secure Summit 2011 to serve as a platform for top industry decision-makers, regulators and innovators to converge and drive forward progress in this fast-growing market.

Concentrating on technologies currently available in the market as well as forthcoming developments, the summit will demonstrate how to combat product theft, diversion, tampering and counterfeiting, improve supply chain management, stay in line with changing international law and maintain a competitive edge. GSS 2011 provides an intensive three days of industry discussion and learning.
Delegates will gain an increased understanding of the current environment, and the technologies and product solutions available.

The contacts that you make at GSS 2011 will enable you to further develop business relationships with your peers and colleagues as well as initiate solutions and ideas with suppliers

Suppliers

The Global Secure Summit 2011 is an opportunity to be involved in an intensive series of pre-arranged meetings with leading executives within the CPG and pharmaceutical industries, leading to new business opportunities and relationships.

Whatever technology, product or solution you offer, your attendance at GSS 2011 will open new doors for future business development.

The invited delegate audience for GSS 2011 include:

Pharmaceutical & Healthcare
Pfizer Inc
Johnson & Johnson
GlaxoSmithkline Plc
Sanofi-Aventis Group
Novartis AG
Roche Holding AG
AstraZeneca PLC
Abbot Laboratories
Merck & Co.,Inc   
Bristol-Myers Squibb Company
Taisho Pharmaceutical
Teva Pharmaceutical Industries
Abbott Laboratories
Cardinal Health Inc
Boehringer Ingelheim
Baxter International
Tyco Healthcare Group
Becton Dickinson
Smith and Nephew
Bayer Healthcare
Moelnlycke Healthcare
Medtronic
Wyeth
Mitsubishi Pharma
Novo Nordisk
Shering-Plough
Sanofi-Aventis SA
Eli Lilly and Co. Indianapolis
Fujisawa Pharmaceutical Co.
Daiichi Pharmaceutical Co.
Alcon Inc.
Organon International Inc.

Personal Care Products
Procter & Gamble Company
Unilever
Sara Lee Corporation
Christian Dior SA
L’Oreal SA
Kimberley-Clark Corporation
Henkel KGaA
LVMH Moet Hennessy Louis Vuitton SA
Colgate-Palmolive Company
Avon Products, Inc
Estee Lauder Companies Inc
Church & Dwight Co., Inc
Wella AG
Yves Rocher Group
Mary Kay Inc
Coty Inc
Alberto Culver Company
Beisdorf AG
Revlon
Clarins
Natura Cosmeticos SA/
PZ Cussons
Kanebo Ltd
Oriflame

Tobacco Industry
Philip Morris USA Inc
R.J Reynolds Tobacco Holdings, Inc
Brown  & Williamson Corp
Carolina Group
Altria Group Inc
Japan Tobacco
Gallaher Group plc
Atladis S.A.
Imperial Tobacco
Swedish Match AB

Consumer Electronics
Microsoft Corp
Apple Inc
Sony Corporation
Nintendo Co., Ltd
Royal Philips Electronics N.V.
Bose Corp

Premium Drinks
Nestle S.A
Coca-Cola Company
Diageo plc
Pernod Ricard
Cadbury Schweppes plc
Sara Lee Corporation
PepsiAmericas,Inc
SABMiller
Bacardi Limited
LVMH Moet Hennessy Louis Vitton SA
Remy Cointreau
FEMSA
E,& J Gallo Winery
Fortune Br